Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Haematologica
|
January 1, 1996
Stomach preservation in low- and high-grade primary gastric lymphomas: preliminary results
C Rabbi, E Aitini, G Cavazzini, et al.
Recenti Progressi in Medicina
|
June 1, 1996
[Testicular lymphomas. A clinico-pathological study of 5 cases and a review of the literature]
M D Zamagni, M Cantore, E Aitini, et al.
Tumori
|
October 24, 2001
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) in locally advanced or metastatic gastric cancer: a single institution experience
E Aitini, C Rabbi, A Mambrini, et al.
Minerva Chirurgica
|
October 22, 1998
[Pulmonary metastasis from an eccrine carcinoma: thoracic perfusion with the aorto-caval stop-flow technique. Description of a clinical case]
A Mambrini, G Cavazzini, F Pari, et al.
Il Giornale Di Chirurgia
|
April 1, 1997
[Combined intra-arterial locoregional and systemic treatment of nonresectable hepatic metastases of colorectal carcinoma]
M Cantore, E Aitini, C Rabbi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study
R Buzzoni, S Pusceddu, E Bajetta, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer
M Cantore, G Fiorentini, G Luppi, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 11, 2005
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology
M Cantore, G Fiorentini, G Luppi, et al.
International Journal of Cancer
|
January 24, 2019
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
O Obazee, L Archibugi, A Andriulli, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Haematologica
|
January 1, 1996
Stomach preservation in low- and high-grade primary gastric lymphomas: preliminary results
C Rabbi, E Aitini, G Cavazzini, et al.
Recenti Progressi in Medicina
|
June 1, 1996
[Testicular lymphomas. A clinico-pathological study of 5 cases and a review of the literature]
M D Zamagni, M Cantore, E Aitini, et al.
Tumori
|
October 24, 2001
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) in locally advanced or metastatic gastric cancer: a single institution experience
E Aitini, C Rabbi, A Mambrini, et al.
Minerva Chirurgica
|
October 22, 1998
[Pulmonary metastasis from an eccrine carcinoma: thoracic perfusion with the aorto-caval stop-flow technique. Description of a clinical case]
A Mambrini, G Cavazzini, F Pari, et al.
Il Giornale Di Chirurgia
|
April 1, 1997
[Combined intra-arterial locoregional and systemic treatment of nonresectable hepatic metastases of colorectal carcinoma]
M Cantore, E Aitini, C Rabbi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study
R Buzzoni, S Pusceddu, E Bajetta, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer
M Cantore, G Fiorentini, G Luppi, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 11, 2005
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology
M Cantore, G Fiorentini, G Luppi, et al.
International Journal of Cancer
|
January 24, 2019
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
O Obazee, L Archibugi, A Andriulli, et al.
Page
of 9